RECRUITING

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Talk to us

Conditions

Head and Neck CancerHead and Neck TumorThoracic TumorThoracic CancerGynecologic CancerGynecologic TumorMelanomaOvarian Cancerthoracic tumorsgynecological tumors21-369Memorial Sloan Kettering Cancer Center

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overarching long-term goal of the Integrative Medicine for Patient-reported Outcomes Values and Experience (IMPROVE) research program is to evaluate whether integrating a virtual mind-body programming, Integrative Medicine at Home (IM@Home), will improve patient perceived values, outcomes, and experiences as they undergo systemic cancer treatment such as chemotherapy, immunotherapy, radiotherapy, targeted agents, cytoreductive surgery.

Official Title

Integrative Medicine for Patient-reported Outcomes, Values, and Experience (IMPROVE)

Quick Facts

Study Start:2021-09-20
Study Completion:2025-09-20
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05053230

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 18 years or older
  2. * Patients with a diagnosis of head and neck tumors, thoracic tumors, gynecological tumors, melanoma, breast cancer, or ovarian cancer
  3. * Actively receiving systemic oncological treatment or radiotherapy, or within 4 weeks of radiotherapy completion or primary cytoreductive surgery
  4. * Worst fatigue over the last 7 days rated 4 or greater on (0-10 scale) (Patients in the ovarian basket will not be required to meet fatigue criteria in order to be enrolled. Patients in the ovarian basket will be eligible for enrollment prior to commencement of chemotherapy)
  5. * Karnofsky score 60 or greater
  6. * Life expectancy greater than six months
  7. * English speaking
  1. * Cognitive impairment that would preclude response to study assessments or require the use of Legally Authorized Representatives
  2. * Unwilling to accept random assignment
  3. * Concurrently enroll onto ongoing competing trials of integrative medicine interventions with symptom/toxicity as primary outcome. Note, however, patient will be allowed to enroll on other therapeutic protocols

Contacts and Locations

Study Contact

Jun Mao, MD, MSCE
CONTACT
646-888-0863
maoj@mskcc.org
Tony Hung, MD
CONTACT
646-608-4127
HungT@mskcc.org

Principal Investigator

Jun Mao, MD, MSCE
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, 07920
United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, New Jersey, 07748
United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, 07645
United States
Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities)
Commack, New York, 11725
United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, 10604
United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, New York, 11553
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Jun Mao, MD, MSCE, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-09-20
Study Completion Date2025-09-20

Study Record Updates

Study Start Date2021-09-20
Study Completion Date2025-09-20

Terms related to this study

Keywords Provided by Researchers

  • Head and Neck Cancer
  • head and neck tumor
  • thoracic tumors
  • gynecological tumors
  • melanoma
  • 21-369
  • Memorial Sloan Kettering Cancer Center
  • ovarian cancer

Additional Relevant MeSH Terms

  • Head and Neck Cancer
  • Head and Neck Tumor
  • Thoracic Tumor
  • Thoracic Cancer
  • Gynecologic Cancer
  • Gynecologic Tumor
  • Melanoma
  • Ovarian Cancer